0.00Open0.03Pre Close0 Volume509 Open Interest765.00Strike Price0.00Turnover704.17%IV0.02%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.0115Delta0.0040Gamma25503.33Leverage Ratio-149.1769Theta0.0000Rho-294.27Eff Leverage0.0003Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet